Results 241 to 250 of about 945,860 (406)
ABSTRACT Introduction There is a growing, national need for properly trained dentists to provide special care dentistry to a transitioning, aging, and medically complex population. This study describes the implementation and initial impact of a novel academic‐community intervention designed to rapidly address this critical gap in provider training and ...
Dan Burch +7 more
wiley +1 more source
Avian Influenza Virus A(H5N1) Genotype D1.1 Is Better Adapted to Human Nasal and Airway Organoids Than Genotype B3.13. [PDF]
Zhang X +16 more
europepmc +1 more source
Abstract This study explores how social enterprises create social and economic value through business models that support ex‐offenders. The work was motivated by a request for help from an entrepreneur wishing to establish a business that supports ex‐offender rehabilitation.
Elizabeth Green +2 more
wiley +1 more source
The Charity Beauty Premium: Satisfying Donors’ “Want” versus “Should” Desires
Cynthia Cryder +2 more
semanticscholar +1 more source
Turning the Tables: Leveraging Purpose as a Strategic Advantage for SMEs
ABSTRACT When executed well, purpose can become a transformative force, turning a business into a breakout success. Despite the wave of purpose‐driven businesses in recent years, the concept of purpose remains underdeveloped. Purpose is a core component of business models but is difficult to retrofit into large corporations, which makes it especially ...
Klaus Heine, Glyn Atwal, Sonja Sperber
wiley +1 more source
Monitoring and evaluation of digital mental health assessments in adults with mild to moderate intellectual disability and concurrent mental illness: a pilot study. [PDF]
Faisal M +9 more
europepmc +1 more source
Making charity effectiveness transparent: building a stakeholder-focused framework of reporting
Noel Hyndman, D. Mcconville
semanticscholar +1 more source
New Biologic and Small Molecule Therapies for Hidradenitis Suppurativa
ABSTRACT Hidradenitis suppurativa (HS) is an inflammatory skin disease that has historically been underdiagnosed and, until recently, under‐researched. Furthermore, the pathophysiology of HS is complex, and not fully understood. Just three biologic medications—adalimumab (anti‐TNF‐α), secukinumab (anti‐IL17A) and bimekizumab (anti‐IL17A/F) are licensed
Emily Pender +2 more
wiley +1 more source

